Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 13, Status: Authorised

PSUSA/00001499/202502

Clinical Trials Information System (CTIS): Walk-in clinic November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 November 2025, 16:00 (CET) to 19 November 2025, 17:00 (CET)

Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Date of authorisation: 08/05/2017, Revision: 18, Status: Authorised

PSUSA/00010915/202501

Human medicines European public assessment report (EPAR): Arexvy, recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E, Date of authorisation: 06/06/2023, Revision: 7, Status: Authorised

PSUSA/00000259/202502

Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 28, Status: Authorised

PSUSA/00003168/202502

Agenda - HMA/EMA Annual Data Forum 2025